2023-11-01 2024-10-31 12987045 Eboracum Surgery Limited false 12987045 2023-11-01 2024-10-31 12987045 uk-bus:Director1 2023-11-01 2024-10-31 12987045 uk-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 12987045 uk-bus:SmallEntities 2023-11-01 2024-10-31 12987045 uk-bus:FullAccounts 2023-11-01 2024-10-31 12987045 uk-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 12987045 2023-11-01 12987045 2024-10-31 12987045 2023-10-31 xbrli:pure iso4217:GBP 12987045 2022-11-01 2023-10-31
Company Registration Number : 12987045 (England and Wales)
12987045
This company is a private limited company
This company sells stuff to other companies
The company was trading for the entire period
Full Accounts
2024-10-31
false
Eboracum Surgery Limited
The accounts were prepared in accordance with FRS102A
The accounts have been audited
2023-11-01
Eboracum Surgery Limited
Unaudited filleted financial statements
For the year ended 31 October 2024
Eboracum Surgery Limited
Contents
For the year ended 31 October 2024

CONTENTS PAGE
Company Information 3
Statement of Financial Position 4
Statement of movement in equity 5
Notes to the Financial Statements 6 - 7


Eboracum Surgery Limited
Company Information
For the year ended 31 October 2024

Company registration number 12987045 (England and Wales)
Director James Smith
Registered office address Pegholme, Bays 61-65 Wharfebank Mills
Ilkley Road
Otley
West Yorkshire
LS21 3JP
Accountant BURROW & CROWE ACCOUNTANTS & BUSINESS ADVISERS LTD
Chartered Management Accountants
Pegholme, Bay 61-65, Wharfebank Mills
Ilkley Road, Otley, Yorkshire, United Kingdom
LS21 3JP
Eboracum Surgery Limited
Statement of Financial Position
For the year ended 31 October 2024

2024 2023
Notes £ £
Fixed assets
Property, plant and equipment 2,077 4,104
5 2,077 4,104
Current assets
Debtors 127,316 130,939
Cash and cash equivalents 38,151 21,328
165,466 152,267
Current liabilities
Creditors: Amounts falling due within one year (1,800) (1,380)
Corporation tax payable (64,312) (60,015)
(66,112) (61,395)
Net current assets/(liabilities) 99,354 90,872
Total assets less current liabilities 101,432 94,976
Net assets/(liabilities) 101,432 94,976
Capital and reserves
Called up share capital 200 100
Retained earnings 101,232 94,876
Shareholder's funds 101,432 94,976
For the year ended 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
The directors have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibility for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the special provisions of the Companies Act 2006 applicable to companies subject to the small companies' regime and in accordance with FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A.
The profit and loss account has not been delivered to the Registrar of Companies in accordance with the special provisions applicable to companies subject to the small entities regime. All the members of the company have consented to the drawing up of the abridged balance sheet.
  • For the year ended 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The director acknowledges their responsibility for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the Board on 28 July 2025
.............................
James Smith (Director)
Company registration number: 12987045
/* == Copy of Frs105 Balance Sheet for XML COntent ============================================================ */
Balance sheet at 2024-10-31 31 October 2024
2024 2023
£ £
Fixed Assets 2,077 4,104
Current Assets 165,466 152,267
Creditors: amounts falling due within one year (66,112) (61,395)
Net current assets/(liabilities) 99,354 90,872
Total assets less current liabilities 101,432 94,976
Net Assets/(liabilities) 101,432 94,976
Capital and Reserves 101,432 94,976
For the year ending 31/10/2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. For the year ending 31-10-2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit for the year in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the small companies provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board of directors on 28 July 2025 2025-07-28 and signed on behalf of the board,
.............................
James Smith
Director
Company registration number: 12987045
Eboracum Surgery Limited
Statement of movement in equity
For the year ended 31 October 2024

Equity share capital Retained earnings Total
£ £ £
As on 01 Nov 2022 - 48,468 48,468
Movement in share capital 100 - 100
Profit/Loss for the year - 54,408 54,408
Dividend paid - (8,000) (8,000)
As on 31 Oct 2023 and 01 Nov 2023 100 94,876 94,976

Movement in share capital 100 - 100
Profit/Loss for the year - 102,381 102,381
Dividend paid - (96,025) (96,025)
As on 31 Oct 2024 200 101,232 101,432
Eboracum Surgery Limited
Notes to the Financial Statements
For the year ended 31 October 2024

(1) General Information
The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is Pegholme, Bays 61-65 Wharfebank Mills, Ilkley Road, Otley, West Yorkshire, LS21 3JP.

(2) Statement of compliance
These individual financial statements have been prepared in accordance with FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A and Companies Act 2006, as applicable to companies subject to the small companies' regime.

(3) Significant Accounting Policies
Basis of Preparation
The financial statements have been prepared on the historical cost basis and in accordance with the Companies Act 2006. The presentation and functional currency of the company is pounds sterling. The financial statements are presented in pound units (£) unless stated otherwise.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. The company recognises revenue when the amount of revenue can be measured reliably, when it is probable that future economic benefits will flow to the entity and when specific criteria have been met as described below.
Sale of goods
Sales of goods are recognised when the company has delivered the goods to the customer, no other significant obligation remains unfulfilled that may affect the customer's acceptance of the products and risks and rewards of ownership have transferred to them.
Rendering of Services
Revenue from provision of services rendered in the reporting period is recognised when the outcome of a transaction for the rendering of services can be estimated reliably in terms of revenue, costs and its stage of completion of the specific transaction at the end of the reporting period. The stage of completion is determined on the basis of the actual completion of a proportion of the total services to be rendered. When the outcome of a service contract cannot be estimated reliably the company only recognises revenue to the extent of the recoverable expenses recognised.
Interest income
Interest income is recognised using the effective interest method.
Property, plant and equipment
Property, plant and equipment is stated at cost less accumulated depreciation and impairment losses. Part of an item of property, plant and equipment having different useful lives are accounted for as separate items.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives, using the straight-line method. The estimated useful lives, residual values and depreciation method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis.

Depreciation is provided to write off the cost less estimated residual value, of each asset over its expected useful life as follows:

Asset class and depreciation rate
Land and Buildings
Plant and Machinery20% reducing balance
Short Leasehold Properties
Investment Properties
Long Leasehold Properties
Commercial Vehicles
Fixtures and Fittings
Equipment33% straight line
Motor Cars
Taxation
Taxation expense represents the aggregate amount of current tax and deferred tax recognised in the reporting period.
Current Tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit before tax as reported in the income statement because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

(4) Employees
During the year, the average number of employees including director was 1 (2023 : 1).

(5) Fixed assets
Tangible

£
Cost
As at 01 November 20238,481
Additions846
As at 31 October 20249,327
Depreciation/Amortisation
As at 01 November 20234,377
For the year2,872
As at 31 October 20247,249
Net book value
As at 31 October 20242,078
As at 31 October 20234,104